phosphodiesterase-5 inhibitor
Showing 1 - 25 of >10,000
MDD Trial in Shibin Al Kawm (Sildenafil Citrate, Placebo oral tablet)
Recruiting
- Major Depressive Disorder
- Sildenafil Citrate
- Placebo oral tablet
-
Shibīn Al Kawm, EgyptFaculty of Medicine
Jan 16, 2023
Congenital Diaphragmatic Hernia, Pulmonary Hypertension Trial in Salt Lake City (Sildenafil Oral Suspension, Placebo)
Not yet recruiting
- Congenital Diaphragmatic Hernia
- Pulmonary Hypertension
- Sildenafil Oral Suspension
- Placebo
-
Salt Lake City, UtahPrimary Children's Hospital
Jan 27, 2022
Erectile Dysfunction, Sexual Dysfunction Trial in Salt Lake City (Natesto Nasal Product, Placebo)
Recruiting
- Erectile Dysfunction
- Sexual Dysfunction
- Natesto Nasal Product
- Placebo
-
Salt Lake City, UtahUniversity of Utah, Division of Urology
Aug 11, 2022
Phosphodiesterase Type 5 Inhibitor to Improve Anabolic
Not yet recruiting
- Sarcopenia
- Tadalafil 5mg
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Jul 25, 2022
MDD Trial in Shibin Al Kawm (Tadalafil 5Mg Tab, Placebo)
Recruiting
- Major Depressive Disorder
- Tadalafil 5Mg Tab
- Placebo
-
Shibīn Al Kawm, Menoufia, EgyptFaculty of Pharmacy
Aug 31, 2021
Erectile Dysfunction Following Radiation Therapy, Phosphodiesterase Inhibitor Adverse Reaction, Platelet- Rich Plasma (PRP)
Active, not recruiting
- Erectile Dysfunction Following Radiation Therapy
- +2 more
- P shot arm ( Autologous Platelet Rich Plasma)
- PDE5i arm
-
Mansoura, Outside U.S./Canada, EgyptMansoura urology and nephrology center
Mar 15, 2023
Sickle Cell People With Pulmonary Hypertension
Completed
- Pulmonary Hypertension
- Sickle Cell Disease
-
Bethesda, MarylandNational Heart, Lung and Blood Institute (NHLBI)
Apr 16, 2021
MDD Trial in Shibeen Elkom (Roflumilast 250Mcg Tab, Placebo)
Recruiting
- Major Depressive Disorder
- Roflumilast 500Mcg Tab
- Placebo
-
Shibeen Elkom, Menoufia, EgyptFaculty of Pharmacy
Jan 16, 2023
Osteoarthritis Trial in Shibin Al Kawm (Cilostazol 50 MG, Placebo)
Recruiting
- Osteoarthritis
- Cilostazol 50 MG
- Placebo
-
Shibīn Al Kawm, Menoufia, EgyptFaculty of Pharmacy
Jul 28, 2022
Schizophrenia Trial in Shibin Al Kawm (Placebo oral tablet, Pentoxifylline)
Completed
- Schizophrenia
- Placebo oral tablet
- Pentoxifylline
-
Shibīn Al Kawm, EgyptFaculty of Medicine
Oct 23, 2022
Carotid Artery Intima Media Thickness Can Predict Response to
Completed
- Erectile Dysfunction Due to Arterial Disease
- CIMT (Carotid artery intima media thickness measurement)
-
Bursa, TurkeyBursa Yuksek Ihtisas Training and Research Hospital
Jan 11, 2023
Metastatic Colorectal Cancer, Cetuximab, Skin Toxicity Trial in Guangzhou (Crisaborole Ointment, Cetuximab)
Recruiting
- Metastatic Colorectal Cancer
- +2 more
- Crisaborole Ointment
- Cetuximab
-
Guangzhou, Guangdong, ChinaWeiWei Xiao
Nov 3, 2023
Benign Prostatic Hyperplasia Trial (Phosphodiesterase 5 Inhibitors, Alpha Blockers, Combined Alpha Blockers and
Not yet recruiting
- Benign Prostatic Hyperplasia
- Phosphodiesterase 5 Inhibitors
- +2 more
- (no location specified)
Feb 10, 2022
Single-ventricle, Pulmonary Hypertension, Univentricular Heart Trial (Sildenafil, Placebos)
Not yet recruiting
- Single-ventricle
- +2 more
- Sildenafil
- Placebos
- (no location specified)
Jan 20, 2022
Fundus Oculi and Erectile Dysfunction
Unknown status
- Erectile Dysfunction
- Dynamic Vessel Analyzer (DVA)
- Phosphodiesterase type 5 Inhibitor (PDE5I)
-
Milan, MI, ItalyOspedale San Raffaele
Jul 20, 2020
Pulmonary Hypertension, COPD Trial (Tadalafil)
Not yet recruiting
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease
- (no location specified)
Apr 25, 2023
Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- +2 more
- (no location specified)
Jul 21, 2023
Diabetes, Type 2 Trial in Gothenburg (Tadalafil, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Tadalafil
- Placebo
-
Gothenburg, SwedenSahlgrenska University Hospital
Feb 10, 2020
Alcohol, Phosphodiesterase Inhibitor, Erectile Dysfunction Trial in Shanghai (TPN171H tablet plus alcohol, alcohol, TPN171H
Completed
- Alcohol
- +2 more
- TPN171H tablet plus alcohol
- +2 more
-
Shanghai, ChinaShanghai Xuhui Central Hospital
May 20, 2022
Erectile Dysfunction Trial in Saint Petersburg (PDE5 inhibitor (tadalafil) and BTL-6000 fSWT, PDE5 inhibitor (tadalafil))
Recruiting
- Erectile Dysfunction
- PDE5 inhibitor (tadalafil) and BTL-6000 fSWT
- PDE5 inhibitor (tadalafil)
-
Saint Petersburg, Russian FederationSBPSU
Apr 10, 2023
Heart Defects, Congenital, Transposition of Great Vessels With Ventricular Inversion Trial in Austria, Switzerland (Tadalafil 20
Completed
- Heart Defects, Congenital
- Transposition of Great Vessels With Ventricular Inversion
- Tadalafil 20 MG
- Placebo 20 MG
-
Wien, Austria
- +6 more
Feb 23, 2022